Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RASAGILINE vs REBAMIPIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RASAGILINE vs REBAMIPIDE: Safety Overview

Metric RASAGILINE REBAMIPIDE
Total FAERS Reports 2,731 427
Deaths Reported 255 32
Death Rate 9.3% 7.5%
Hospitalizations 961 222
Average Patient Age 71.0 yrs 63.7 yrs
% Female Patients 46.2% 56.6%
FDA Approval Date Apr 9, 2024 N/A
Manufacturer Ascend Laboratories, LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A